Professional Overview

Mark Burcin is a seasoned executive with a strong background in quality and compliance, currently serving as Executive Vice President, Quality and Compliance at MeriCal. His key expertise areas include quality assurance, regulatory affairs, and environmental health and safety, with a focus on the pharmaceutical and life sciences industries.

Experience Summary

Current Role

Mark Burcin is currently the Executive Vice President, Quality and Compliance at MeriCal, a position he has held since October 2023. In this role, he is responsible for overseeing quality and compliance functions across the organization. Prior to this, he held the position of Vice President, Quality, Regulatory and EHS at MeriCal from March 2023 to Present.

Career Progression

Mark Burcin's career trajectory spans over two decades, with notable previous roles including Vice President, Quality and Regulatory Affairs at MeriCal, Head Of Quality at BASF, Senior Director QA/QC at Verenium, Quality Assurance Manager at Natural Alternatives International, Sr. Process Chemist at Biosite Diagnostics, Chemist II at La Jolla Pharmaceutical Company, and Chemist at Chiron Mimotopes Peptide Systems. Throughout his career, he has demonstrated significant growth and contributions to his organizations.

Areas of Expertise

Mark Burcin's areas of expertise include industry-specific skills such as quality assurance, regulatory affairs, and environmental health and safety. He also possesses technical competencies in chemistry and process development, as well as leadership and management capabilities.

Professional Impact

Although specific details on notable projects or initiatives are not provided, Mark Burcin's career progression and current role suggest significant contributions to the pharmaceutical and life sciences industries.

Conclusion

Mark Burcin is a seasoned executive with a strong background in quality and compliance. His current role as Executive Vice President, Quality and Compliance at MeriCal reflects his professional trajectory and current focus on quality and compliance in the pharmaceutical and life sciences industries. His value proposition lies in his expertise and experience in quality assurance, regulatory affairs, and environmental health and safety, making him a valuable asset to his organization.